Displaying 1-20 of 32 results for

Policy Options to Improve Data Sharing Between State and Local Health Departments Organizational policies on data sharing between state and local public health agencies. This report explores organizational policies related to data sharing between state and local public health departments. ASTHO, in collaboration with the National Association of County and City Health Officials and the Network for Public Health Law developed this report, which aims to serve as a guide for state and local public health leaders as they consider organizational policy options to improve state and local data-sharing efforts. Get the Report (PDF) website yes

Moving from Design to Implementation: Lessons on Expanding Contraception Access in New Jersey Liz Gipson, Jahira Sterling, Lauren Moran, Brittany Lee, Sophia Durant Lessons on expanding contraception access in New Jersey. Public sector health leaders play a critical role in influencing reproductive health policy design and program implementation. As the key authorities on state programs, public sector leaders foster necessary collaboration between community partners and other state agencies. In New Jersey, state officials are implementing two contraception access bills, S 413 and S 275, enacted in 2022 and 2023 respectively. This report details lessons learned from New Jersey’s cross-sector and interagency collaboration, which can guide public sector leaders in other states working to expand access to reproductive health services. Get the Report (PDF) website yes

The OD2A Health Equity Needs Assessment is designed to assess the support, technical assistance, and training that state, local, and territorial health agencies need to move health equity forward within their OD2A programs.

Learn about public health strategies for preventing chronic disease that intersect with themes in MAHA report including nutrition and physical activity.

Colleen Arceneaux and Jantz Malbrue from the Louisiana Department of Health to discuss why forgoing community health worker certification was the right course of action for their state.

ASTHO conducted focus groups to examine overdose-related issues and identify potential engagement opportunities for public health and public safety around overdose prevention. This brief outlines key takeaways and is designed to serve as a guide for public health building and strengthening relationships with public safety.

Pharmacies have long been instrumental partners in providing lifesaving vaccines nationwide. As state and territorial health officials evaluate their COVID-19 response, planners must include input from the pharmacy community when identifying areas for improvement, as well as best vaccination practices in advance of future public health emergencies.

Each year, ASTHO tracks and analyzes key legislation that impacts public health, and highlights the emerging trends for our members. While the bulk of the tracked legislation arises in state legislatures, ASTHO also follows legislation from the territories and Freely Associated States, jurisdictions collectively referred to as the insular areas. The insular areas often face different challenges than the states, while also sharing many common concerns. This post contains a brief look at some of the public health related legislation introduced in the insular areas during their current legislative sessions.

The Special Supplemental Nutrition Program for Women, Infants, and Children is a targeted public health nutrition program designed to support nutrition and health behaviors that reach low-income families. The program is funded through discretionary funds to the United States Department of Agriculture and administered by each state’s health or public health department. The department then contracts with county health departments, local health centers, hospitals, federally qualified health centers, and private nonprofits to deliver community-based clinic services.

May is Mental Health Awareness Month and the importance of continued mental health promotion and suicide prevention efforts during the COVID-19 pandemic. As we address the physical effects of COVID-19 through social distancing, mask wearing, and vaccination, we still need to prioritize mental health and well-being during and after the pandemic. A recent Morbidity and Mortality Weekly Report found increases in adults reporting symptoms of anxiety or depression (36.4% to 41.5%) and unmet mental health care need (9.2% to 11.7%) between Aug. 2020 to Feb. 2021.

Guest post by Jennifer Orme-Zavaleta, PhD. Last month, I had the pleasure of joining ASTHO’s Vice President for Health Security, Meredith Allen, EPA Administrator Michael Regan, and the president of the Environmental Council of States (ECOS) Patrick McDonnell at the ECOS Spring Meeting. The event marked the start of a strong state-federal relationship under the new EPA leadership, highlighted by the extension of a formal Memorandum of Agreement (MOA) reaffirming a partnership between our three organizations to advance cooperative initiatives in pursuit of environmental health.

Economic security and well-being, job stability, access to safe and affordable housing, access to healthy and nutritious foods, and access to resources to manage mental and physical health—all of these things impact individual, family, and community health. The COVID-19 pandemic has fundamentally impacted each of these social determinants of health for many Americans. Furthermore, some communities and industries have faced harder economic impacts than others, including households with low incomes, non-white households, and households with children. Human services and public health leaders can collaborate to make sure we are rebuilding systems and programs in a way that creates healthier, more resilient families and communities.

The adage “what gets measured, gets done” has had staying power for a reason. When we can accurately describe conditions, quantify impact, and elucidate connections, we have a better chance at taking collective (and effective) action to tackle even the most challenging problems facing our communities. The National Survey of Children’s Health is a powerful tool to provide this critical information to researchers, policymakers, and state-level decision makers.

In anticipation of the upcoming presidential election in November, the Republican and Democratic National Committees released their platforms. These platforms provide an overview of values, policies, positions, and principles on various domestic and foreign issues deemed most important to the two political parties. For the upcoming 2020 elections, delegates of the Republican National Committee approved a resolution that renewed support for the platform adopted in 2016 and the Democratic National Committee approved a 2020 platform. Although both platforms touch on a diverse list of issues, there are several that are of interest to health and public health.

The opioid crisis continues to claim the lives of thousands across the United States and has cost the economy billions in health care, mortality, and criminal justice costs. In 2018, it’s estimated that 67,367 people died of overdose, with opioids (prescription opioids, heroin, and other synthetic opioids other than methadone) made up almost 70% of overdose deaths. Provisional data for the twelve-month period ending December 2019 shows that there were 71,130 overdose deaths, with 50,178 overdose deaths attributed to opioids. The COVID-19 pandemic has also exacerbated the drug overdose crisis. Data shows that in the time of continued lockdowns and social distancing that overdose rates have increased, indicating a sustained need to support people with substance use disorder.

State and local jurisdictions are developing Ending the HOV Epidemic plans. The EHE initiative has largely focused on four key strategies: Diagnose, Treat, Prevent, and Respond to potential outbreaks. The EHE initiative set a goal to increase the estimated percentage of individuals with indications for PrEP who have been prescribed PrEP to 50 percent by 2025, as the national average as of 2018 is 18.2 percent. Several states have proposed and/or passed legislation to ensure insurance coverage of PrEP and/or to allow pharmacists to prescribe and dispense it. In addition to efforts addressing cost-related challenges, states can also employ innovative approaches—such as telehealth—to expand access to PrEP services to those in need.

On Dec. 3, the International Day of People with Disabilities commemorates disability rights and brings awareness to essential issues for those with disabilities by promoting the “well-being of persons with disabilities in all spheres of society.” While the ADA laid a critical foundation for disability rights, the work to ensure equitable access to services and needs continues, including access to state and local emergency preparedness and response activities like crisis communication, access to resources, allocation of vaccine and other medical countermeasures, and transportation.

In February 2023, ASTHO staff traveled to Koror, Palau for a four-day health equity summit and held workshops to identify, select, and prioritize measures for Palau’s health equity work.

State Health Officials, Medical Experts, and Safety Advocates Call on FDA to Seek Removal of Ultra-High Dosage Opioids ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO), together with the Physicians for Responsible Opioid Prescribing, the National Safety Council, and the American College of Medical Toxicology, filed a petition today requesting that FDA seek removal of ultra-high dosage opioids from the market. The petition shows how the risks of these products outweigh their benefits. An example of an ultra-high dosage opioid is the OxyContin 80 mg tablet, which is equivalent to 24 regular strength Vicodin in one pill. “ASTHO continues to work with state health leadership across the nation to combat the opioid epidemic,” says Mike Fraser, ASTHO’s executive director. “These ultra-high dosage opioids are extremely deadly when misused and we hope that FDA responds accordingly to our request to remove them from the market.” The request for FDA to seek removal of these products comes on the heels of a report released last month by the National Academies of Sciences, Engineering, and Medicine (NASEM) calling on FDA to overhaul its opioid policies using a new framework that factors in misuse. Scott Gottlieb, the recently appointed FDA commissioner, enthusiastically endorsed the NASEM report and the new framework for making opioid approval and removal decisions. State and territorial health agencies, along with partners across the nation, are working to prevent substance misuse and addiction, and working to educate providers on appropriate guidelines for treating pain. In 2015, roughly 11.5 million Americans misused prescription opioids. The most common form of misuse involves borrowing opioids from friends or family to relieve physical pain. When an ultra-high dosage pill is taken by someone with a low tolerance to opioids, fatal respiratory depression can occur. Drug overdoses have become the leading cause of accidental death in the United States, surpassing motor vehicle accidents. Pharmaceutical companies began introducing ultra-high dosage opioids about 20 years ago as the practice of prescribing long-term, high dose opioids became more common. In response to soaring increases in opioid addiction and overdose deaths, CDC and state health officials across the country are now urging the medical community to prescribe more judiciously and in lower doses when these medicines are indicated. ASTHO Press Release Boilerplate website yes

Health Officials and Attorneys General Convene to Discuss Legal and Public Health Solutions to Opioid Epidemic ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) and the National Attorneys General Training and Research Institute, a branch of the National Association of Attorneys General, held an inaugural three-day summit with health officials and attorneys general on Nov. 14-16 to promote coordination across public health, law enforcement, and medical professionals to address opioid abuse and misuse, an epidemic that claims the lives of 78 people each day and has now become one of the nation’s most urgent public health threats. At the meeting, health officials and attorneys general discussed the importance of working together to change the conversation about people with substance use disorders, and the need to move from punitive approaches toward compassionate, evidence-based treatment. Health and law enforcement officials are intensifying efforts to improve prescribing practices, apply effective regulatory and enforcement measures, and eliminate stigma and misconceptions about individuals who seek addiction treatment. “We need to reframe the conversation about addiction, from one about bad choices and moral failings to one about chronic health conditions that affect the brain,” says Jay Butler, ASTHO president and chief medical officer for the Alaska Department of Health and Social Services. “Together, public health and law enforcement officials have a critical role to play in ending this epidemic that continues to devastate our families and communities.” ASTHO’s 2017 President’s Challenge, led by Butler, centers around public health approaches to preventing substance misuse and addictions. Through the challenge, ASTHO will unite and rally state health officials, affiliates, and other cross-sector partners to take action on this critical and urgent public health issue within states and communities. State health officials will work to expand primary prevention efforts in their states to educate consumers, prescribers, families, policymakers, and other partners about opioid use, and address risk factors in communities to reduce demand for drugs and other addictive substances. U.S. Surgeon General Vivek Murthy and Office of National Drug Control Policy Director Michael Botticelli also delivered remarks on Monday, calling for greater integration of substance use disorder services into the healthcare system so that addiction can be treated with the same precision and urgency as other health conditions like diabetes, heart disease, or cancer. Nationally recognized experts and thought leaders from the National Institute on Drug Abuse, CDC’s National Center for Injury Prevention and Control, the Substance Abuse and Mental Health Services Administration, the American Medical Association, and the Johns Hopkins Bloomberg School of Public Health also described federal and state policy options, strategies for engaging medical professionals, and promising community-based prevention initiatives. ASTHO Press Release Boilerplate website yes